How To Speed Up the Search for Cures Through a Change in Probability Theory

If the FDA follows through with the proposed guidelines, and they are not fatally twisted by pressure from the medical ...
JD Supra

FDA: Drug & Device Advisory | Frequentist or Bayesian? All Roads Lead to Smarter Trials with FDA’s New Bayesian Guidance

Jessica Ritsick, Yifan Wang, Ph.D. Our FDA: Drug & Device Team analyzes the Food and Drug Administration’s new guidance on Bayesian approaches to innovative drug trials, providing greater clarity on ...